SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-027409
Filing Date
2021-11-05
Accepted
2021-11-05 17:17:36
Documents
13
Period of Report
2021-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41858
2 ex2-1.htm EX-2.1 1363466
  Complete submission text file 0001493152-21-027409.txt   1746034

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrzm-20211105.xsd EX-101.SCH 3024
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrzm-20211105_lab.xml EX-101.LAB 34239
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrzm-20211105_pre.xml EX-101.PRE 22358
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3391
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 211385713
SIC: 2834 Pharmaceutical Preparations